Cargando…
Overcoming Biopharmaceutical Interferents for Quantitation of Host Cell DNA Using an Automated, High-Throughput Methodology
The rapid development of biologics and vaccines in response to the current pandemic has highlighted the need for robust platform assays to characterize diverse biopharmaceuticals. A critical aspect of biopharmaceutical development is achieving a highly pure product, especially with respect to residu...
Autores principales: | Lauro, Mackenzie L., Bowman, Amy M., Smith, Joseph P., Gaye, Susannah N., Acevedo-Skrip, Jillian, DePhillips, Pete A., Loughney, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735023/ https://www.ncbi.nlm.nih.gov/pubmed/36482268 http://dx.doi.org/10.1208/s12248-022-00764-4 |
Ejemplares similares
-
Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA–LNP-Based Vaccines
por: Patel, Nisarg, et al.
Publicado: (2023) -
Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective
por: Rémy, Benjamin, et al.
Publicado: (2018) -
Automated N-Glycosylation Sequencing Of Biopharmaceuticals By Capillary Electrophoresis
por: Szigeti, Marton, et al.
Publicado: (2017) -
Biopharmaceuticals : biochemistry and biotechnology
por: Walsh, Gary
Publicado: (2003) -
Biopharmaceuticals : biochemistry and biotechnology /
por: Walsh, Gary
Publicado: (1998)